Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Non-cash Items (2020 - 2021)

Avidity Biosciences (RNA) has disclosed Non-cash Items for 2 consecutive years, with $59.0 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Non-cash Items rose 10502.52% year-over-year to $59.0 million, compared with a TTM value of $59.0 million through Dec 2021, up 10502.52%, and an annual FY2021 reading of $59.0 million, up 10502.52% over the prior year.
  • Non-cash Items was $59.0 million for Q4 2021 at Avidity Biosciences, up from $556000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $59.0 million in Q4 2021 and bottomed at $556000.0 in Q4 2020.